Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Linsitinib | 0.031623 | uM | 10 | 312.50 | 95.00 | 288.67 | 231.25 | 1.2601 | 1.4130 |
| MCF7 | Linsitinib | 0.1 | uM | 10 | 312.50 | 95.00 | 292.00 | 231.25 | 1.2691 | 1.4166 |
| MCF7 | Linsitinib | 0.31623 | uM | 10 | 312.50 | 95.00 | 245.67 | 231.25 | 1.0537 | 1.0615 |
| MCF7 | Linsitinib | 1 | uM | 10 | 312.50 | 95.00 | 186.00 | 231.25 | 0.8104 | 0.7028 |
| MCF7 | Linsitinib | 3.1623 | uM | 10 | 312.50 | 95.00 | 150.33 | 231.25 | 0.6445 | 0.4061 |
| MCF7 | Linsitinib | 10 | uM | 10 | 312.50 | 95.00 | 158.00 | 231.25 | 0.6816 | 0.4777 |
| MCF7 | Linsitinib | 19.9526 | uM | 10 | 312.50 | 95.00 | 127.67 | 231.25 | 0.5494 | 0.2482 |
| MCF7 | Palbociclib | 0.0033113 | uM | 10 | 312.50 | 95.00 | 688.67 | 597.50 | 1.3067 | 1.3290 |
| MCF7 | Palbociclib | 0.01 | uM | 10 | 312.50 | 95.00 | 697.33 | 597.50 | 1.2604 | 1.3002 |
| MCF7 | Palbociclib | 0.031623 | uM | 10 | 312.50 | 95.00 | 466.67 | 597.50 | 0.8622 | 0.9309 |
| MCF7 | Palbociclib | 0.1 | uM | 10 | 312.50 | 95.00 | 535.67 | 597.50 | 0.9226 | 0.9428 |
| MCF7 | Palbociclib | 0.31623 | uM | 10 | 312.50 | 95.00 | 418.00 | 597.50 | 0.7026 | 0.7076 |
| MCF7 | Palbociclib | 1 | uM | 10 | 312.50 | 95.00 | 274.00 | 597.50 | 0.4428 | 0.3660 |
| MCF7 | Palbociclib | 3.1623 | uM | 10 | 312.50 | 95.00 | 216.67 | 597.50 | 0.4118 | 0.3671 |
| MCF7 | Palbociclib | 10 | uM | 10 | 312.50 | 95.00 | 204.67 | 597.50 | 0.3916 | 0.3361 |
| MCF7 | Palbociclib | 19.9526 | uM | 10 | 312.50 | 95.00 | 234.67 | 597.50 | 0.4415 | 0.4025 |
| MCF7 | 17-AAG | 0.0016596 | uM | 10 | 625.00 | 172.23 | 423.00 | 434.17 | 0.9799 | 0.9739 |
| MCF7 | 17-AAG | 0.0033113 | uM | 10 | 625.00 | 172.23 | 469.67 | 434.17 | 1.0836 | 1.1207 |
| MCF7 | 17-AAG | 0.01 | uM | 10 | 625.00 | 172.23 | 402.67 | 434.17 | 0.9245 | 0.8775 |
| MCF7 | 17-AAG | 0.031623 | uM | 10 | 625.00 | 172.23 | 246.33 | 434.17 | 0.5693 | 0.3105 |
| MCF7 | 17-AAG | 0.1 | uM | 10 | 625.00 | 172.23 | 182.67 | 434.17 | 0.4200 | 0.0401 |
| MCF7 | 17-AAG | 0.31623 | uM | 10 | 625.00 | 172.23 | 167.00 | 434.17 | 0.3838 | -0.0272 |
| MCF7 | 17-AAG | 1 | uM | 10 | 625.00 | 172.23 | 160.00 | 434.17 | 0.3691 | -0.0546 |
| MCF7 | 17-AAG | 3.1623 | uM | 10 | 625.00 | 172.23 | 145.00 | 434.17 | 0.3339 | -0.1231 |
| MCF7 | 17-AAG | 10 | uM | 10 | 625.00 | 172.23 | 136.67 | 434.17 | 0.3165 | -0.1594 |